In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Regeneron's current price is substantially below its PERT-weighted fair value of $1,464, indicating significant upside potential. High confidence in DCF and analyst targets contrasts with modest growth scores and elevated Monte Carlo volatility, highlighting risk alongside opportunity. Absence of downside scenarios below current price suggests asymmetric risk-reward.